Career Enhancement Program
职业提升计划
基本信息
- 批准号:10494113
- 负责人:
- 金额:$ 9.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAreaAwardBasic ScienceCaliforniaCancer BiologyCancer CenterChildClinicalClinical InvestigatorClinical SciencesCommunicationCommunitiesDataDevelopmentDisciplineDiseaseEducationEnsureExtramural ActivitiesFacultyFeedbackFoundationsFundingFunding OpportunitiesFutureGoalsHealth SciencesHistorically Black Colleges and UniversitiesHumanHuman DevelopmentIndianaIndividualInfrastructureInstitutionInternationalKnowledgeLeadershipLinkMalignant NeoplasmsMemorial Sloan-Kettering Cancer CenterMentorsMentorshipMissionMonitorMutationNF1 geneNF1 mutationNational Cancer InstituteNatureNeurofibromatosesPathologyPediatric HospitalsPediatric OncologyPediatric Oncology GroupPhiladelphiaPre-Clinical ModelProcessProfessional OrganizationsProgram DevelopmentRequest for ApplicationsResearchResearch PersonnelResourcesRoleSan FranciscoScheduleScienceScientistSex OrientationSignal TransductionSiteSocietiesStructureTalentsTexasTextilesTherapeuticTherapeutic TrialsTrainingTraining ProgramsTranslational ResearchUnderrepresented MinorityUnderrepresented PopulationsUniversitiesWorkanticancer researchbasecancer therapycareercareer developmentclinical outcome assessmentclinical translationdesigndevelopmental diseasedisabilityearly-career facultyeffective therapyefficacy validationfaculty supporthyperactive Rasinnovationinstructormeetingsmemberminority investigatorneoplasm therapyneuro-oncologynext generationpharmacokinetics and pharmacodynamicspreclinical studyprofessorprogramsracial and ethnicrecruitsenior facultyskillssuccesstranslational scientisttumor
项目摘要
ABSTRACT– CAREER ENCHANCEMENT PROGRAM
The DHART SPORE Career Enhancement Program (CEP) supports faculty at the Instructor and Assistant
Professor levels to engage in translational research focused on NF1/Rasopathy disorders and cancer. The
primary goal of the CEP is to advance the careers of early stage investigators who are developing innovative
research related to the goal of implementing more effective and less toxic therapies for cancers characterized
by NF1/Ras. The multi-institutional nature of this SPORE leverages a large and talented pool of early career
faculty from multiple disciplines. Each institution views the CEP as a vehicle for recruiting and advancing the
careers of early stage translational scientists. Collectively, they have committed $1.3 million to the current
award and $1.65 million to the renewal to support the Developmental Programs of the DHART SPORE (CEP
and DRP). The Specific Aims of the CEP are to: (1) support early stage investigators as they develop
innovative research programs that contribute new knowledge to NF1-related cancer research while generating
preliminary data that will allow successful future independent extramural funding; (2) provide early stage
researchers with training that will equip them with essential skills and knowledge for success as independent
investigators; and, (3) mentor early stage translational researchers through regularly scheduled one-on-one
mentor meetings and a structured Individual Development Program (IDP) to facilitate integration into the fabric
of the SPORE. The CEP has a special emphasis on supporting the recruitment of underrepresented minority
investigators (URM). The DHART SPORE will link vertically and horizontally with diversity programs at all of
the consortium institutions and ensure maximum exposure of the CEP mentorship and funding opportunities to
URM across the seven DHART SPORE sites. Further, requests for applications (RFA) will be shared with
Historically Black Colleges and Universities and professional organizations representing communities under-
represented in biomedical science. RFAs are already sent outside of the DHART SPORE sites via the
Children’s Tumor Foundation and Neurofibromatosis Therapeutic Acceleration Program. We are expanding
this recruitment effort to include the Society for Neuro-Oncology, RASopathies Network USA, the Children’s
Oncology Group. The goal is to fund two CEP proposals per year ($50,000 - $75,000/proposal). Requests for
applications will be announced twice a year via broad communications to all groups listed above to maximize
opportunities for recruitment of diverse scientists and science. CEP opportunities will also be highlighted at
professional meetings throughout the year. Applications for CEP support will be evaluated through a
competitive process with review by a Developmental Programs Steering Committee comprised of senor
scientists from the DHART SPORE with oversight and guidance from the SPORE External and Internal
Advisory Boards.
摘要-职业提升计划
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KEVIN M. SHANNON其他文献
KEVIN M. SHANNON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KEVIN M. SHANNON', 18)}}的其他基金
In Vivo Functional Analysis of Chromosome 7q22 Deletions in Myeloid Malignancies
骨髓恶性肿瘤中染色体 7q22 缺失的体内功能分析
- 批准号:
9924474 - 财政年份:2017
- 资助金额:
$ 9.39万 - 项目类别:
Selectively Targeting Oncogenic NRAS in Cancer
选择性靶向癌症中的致癌 NRAS
- 批准号:
10372214 - 财政年份:2015
- 资助金额:
$ 9.39万 - 项目类别:
Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia
项目3:MEK抑制对幼年粒单核细胞白血病的疗效
- 批准号:
8932164 - 财政年份:2015
- 资助金额:
$ 9.39万 - 项目类别:
Selectively Targeting Oncogenic NRAS in Cancer
选择性靶向癌症中的致癌 NRAS
- 批准号:
10209682 - 财政年份:2015
- 资助金额:
$ 9.39万 - 项目类别:
Selectively Targeting Oncogenic NRAS in Cancer
选择性靶向癌症中的致癌 NRAS
- 批准号:
9040123 - 财政年份:2015
- 资助金额:
$ 9.39万 - 项目类别:
Selectively Targeting Oncogenic NRAS in Cancer
选择性靶向癌症中的致癌 NRAS
- 批准号:
10610346 - 财政年份:2015
- 资助金额:
$ 9.39万 - 项目类别:
PROJECT 3: A High Content Clinical Trial of the MEK inhibitor Trametinib in JMML
项目 3:MEK 抑制剂 Trametinib 在 JMML 中的高内涵临床试验
- 批准号:
10270583 - 财政年份:2015
- 资助金额:
$ 9.39万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 9.39万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 9.39万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 9.39万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 9.39万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 9.39万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 9.39万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 9.39万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 9.39万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 9.39万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 9.39万 - 项目类别:
Research Grant